Sumitomo Mitsui Trust Group Inc. Purchases 5,322 Shares of Teleflex Incorporated (NYSE:TFX)

Sumitomo Mitsui Trust Group Inc. grew its position in Teleflex Incorporated (NYSE:TFX) by 5.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 108,231 shares of the medical technology company’s stock after acquiring an additional 5,322 shares during the period. Sumitomo Mitsui Trust Group Inc. owned 0.23% of Teleflex worth $19,263,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of the stock. Confluence Wealth Services Inc. raised its position in Teleflex by 39.6% during the 4th quarter. Confluence Wealth Services Inc. now owns 1,410 shares of the medical technology company’s stock worth $255,000 after purchasing an additional 400 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in Teleflex by 35.1% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after purchasing an additional 1,527 shares during the last quarter. Hager Investment Management Services LLC bought a new position in Teleflex during the 4th quarter worth $77,000. Boston Trust Walden Corp raised its position in Teleflex by 3.9% during the 4th quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company’s stock worth $52,435,000 after purchasing an additional 11,052 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. raised its position in Teleflex by 48.3% during the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 2,250 shares of the medical technology company’s stock worth $400,000 after purchasing an additional 733 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Performance

Shares of TFX opened at $168.28 on Thursday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a 50-day moving average of $179.25 and a 200-day moving average of $210.37. The company has a market cap of $7.81 billion, a PE ratio of 33.46, a P/E/G ratio of 1.72 and a beta of 1.16. Teleflex Incorporated has a one year low of $167.78 and a one year high of $256.85.

Analyst Ratings Changes

Several research analysts recently issued reports on TFX shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Mizuho decreased their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Truist Financial decreased their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Teleflex currently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.